Nano-X Imaging Ltd.
ILFinancials
Valuation Metrics
Nano-X Imaging Ltd.'s Market Cap is $52M. At end of 2025 it was $180M. Ranked #3099 of 3,121 in US market (top 99%), #1442 of 1,463 on NASDAQ (top 99%), #203 of 205 in Health Care Equipment & Services (top 99%) by Market Cap.
Investment Metrics(as of 2026-09-18)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $52M | US#3,099/3,121 Sec#203/205 |
| Revenue | $15M | US#2,824/3,121 Sec#198/205 |
| Net Income | $-76M | US—/3,121 Sec—/205 |
| Total Assets | $146M | US#3,034/3,121 Sec#194/205 |
| Net Assets | $126M | US#2,782/3,121 Sec#176/205 |
| Employees | 197 | US#2,497/3,121 Sec#172/205 |
| Value | ||
| P/B | 0.41x | US#53/3,121 Sec#3/205 |
| P/S | 3.59x | US#2,011/3,121 Sec#137/205 |
| FCF Yield | -98.12% | US—/3,121 Sec—/205 |
| Profitability | ||
| ROE | -60.21% | US#2,720/3,121 Sec#175/205 |
| ROA | -52.17% | US#2,996/3,121 Sec#199/205 |
| Op. Margin | -422.95% | US#2,802/3,121 Sec#198/205 |
| Revenue Growth | 25.74% | US#511/3,121 Sec#29/205 |
| Financial Health | ||
| Debt Ratio | 15.41% | US#179/3,121 Sec#16/205 |
| Total Debt | $8M | US#2,868/3,121 Sec#189/205 |
| FCF | $-51M | US#2,528/3,121 Sec#178/205 |
| Cash | $44M | US#2,634/3,121 Sec#170/205 |
| Current Ratio | 3.64x | US#643/3,121 Sec#64/205 |
| Performance | ||
| 1Y Return | -82.02% | US#3,103/3,121 Sec#202/205 |
| 1M Return | -19.58% | US#2,585/3,121 Sec#176/205 |
| From 52W High | -84.12% | US#3,099/3,121 Sec#203/205 |
| 1Y MDD | -84.90% | US#3,092/3,121 Sec#202/205 |
| Trading | ||
| Volume | 595,464 shares | US#1,604/3,121 Sec#100/205 |
| Trading Value | $454178.00 | US#3,056/3,121 Sec#197/205 |
| Per Share | ||
| EPS | $-1.09 | US—/3,121 Sec—/205 |
| BPS | $1.81 | US#2,590/3,121 Sec#170/205 |
Company Info
Nano-X Imaging Ltd. specializes in developing a commercial-grade tomographic imaging device that incorporates an innovative digital X-ray source, which leverages a digital micro-electro-mechanical systems (MEMS) semiconductor cathode. Beyond its hardware focus, the company also delivers teleradiology services and creates artificial intelligence (AI) applications tailored for practical use in medical imaging. Its core offerings include the Nanox.ARC, a prototype medical imaging system that integrates its proprietary digital X-ray technology, and Nanox.CLOUD, a complementary cloud-based software platform envisioned to facilitate medical screening as a service. Nano-X also operates Nanox.MARKETPLACE, a platform designed to connect imaging facilities and customers with radiologists for efficient remote interpretation of medical scans. Additionally, the company provides AI-driven software solutions to a wide range of healthcare entities, including hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers. These solutions are designed to analyze data from existing computed tomography (CT) scans to identify or predict undiagnosed or underdiagnosed medical conditions, such as osteoporosis and cardiovascular disease. Nano-X further offers Teleradiology Services, delivering remote imaging interpretation to radiology practices, hospitals, medical clinics, diagnostic imaging centers, urgent care facilities, and multi-specialty physician groups. Founded in 2011, Nano-X Imaging Ltd. is headquartered in Neve Ilan, Israel.